The Effect of COVID-19 on Multiple Sclerosis Relapse: A Systematic Review and Meta-analysis
出版年份 2023 全文链接
标题
The Effect of COVID-19 on Multiple Sclerosis Relapse: A Systematic Review and Meta-analysis
作者
关键词
-
出版物
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 105128
出版商
Elsevier BV
发表日期
2023-11-05
DOI
10.1016/j.msard.2023.105128
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
- (2023) Maria-Ioanna Stefanou et al. Multiple Sclerosis Journal
- Reactivation of herpesviruses during COVID‐19: A systematic review and meta‐analysis
- (2023) Arman Shafiee et al. REVIEWS IN MEDICAL VIROLOGY
- SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study
- (2023) Marco Vercellino et al. Multiple Sclerosis and Related Disorders
- Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study
- (2022) Masoud Etemadifar et al. BMC Neurology
- Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
- (2022) Maddalena Sparaco et al. NEUROLOGICAL SCIENCES
- Epstein–Barr virus and COVID‐19
- (2022) Arman Shafiee et al. JOURNAL OF MEDICAL VIROLOGY
- Long‐term outcome after COVID ‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
- (2022) Gabriel Bsteh et al. EUROPEAN JOURNAL OF NEUROLOGY
- COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
- (2022) Sarah E. Conway et al. Multiple Sclerosis and Related Disorders
- Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
- (2022) Sepideh Paybast et al. NEUROLOGICAL SCIENCES
- The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study
- (2022) Fawzi Babtain et al. Multiple Sclerosis and Related Disorders
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- COVID-19 as a Trigger of Brain Autoimmunity
- (2021) Mayuri Gupta et al. ACS Chemical Neuroscience
- Empirical Comparisons of 12 Meta-analysis Methods for Synthesizing Proportions of Binary Outcomes
- (2021) Lifeng Lin et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Association of CNS demyelination and COVID-19 infection: an updated systematic review
- (2021) Ismail Ibrahim Ismail et al. JOURNAL OF NEUROLOGY
- Secondary Progressive Multiple Sclerosis
- (2021) Bruce A.C. Cree et al. NEUROLOGY
- Emerging neurotropic features of SARS-CoV-2
- (2021) Wen-Rong Zhan et al. Journal of Molecular Cell Biology
- COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
- (2021) Masoud Etemadifar et al. Multiple Sclerosis and Related Disorders
- COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
- (2021) Afagh Garjani et al. Multiple Sclerosis and Related Disorders
- COVID-19 Among Patients With Multiple Sclerosis
- (2021) Mahdi Barzegar et al. Neurology-Neuroimmunology & Neuroinflammation
- Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions
- (2021) Ettore Beghi et al. JOURNAL OF NEUROLOGY
- COVID-19 in multiple sclerosis: Experience from North India
- (2021) Dheeraj Khurana et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The effect of glucocorticoids on mortality in severe COVID-19 patients
- (2021) Guang-Qing Yu et al. MEDICINE
- Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland
- (2021) Agata Czarnowska et al. Journal of Clinical Medicine
- Neurological Implications of COVID-19 Infections
- (2020) Edward J. Needham et al. Neurocritical Care
- Guillain–Barré Syndrome Associated with SARS-CoV-2
- (2020) Gianpaolo Toscano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurologic Features in Severe SARS-CoV-2 Infection
- (2020) Julie Helms et al. NEW ENGLAND JOURNAL OF MEDICINE
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- (2020) Ross W Paterson et al. BRAIN
- Neurological associations of COVID-19
- (2020) Mark A Ellul et al. LANCET NEUROLOGY
- Meta-analysis of Proportions Using Generalized Linear Mixed Models
- (2020) Lifeng Lin et al. EPIDEMIOLOGY
- Possible routes of SARS‐CoV‐2 invasion in brain: In context of neurological symptoms in COVID‐19 patients
- (2020) Ashutosh Kumar et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Does COVID‐19 contribute to development of neurological disease?
- (2020) Arehally M. Mahalakshmi et al. Immunity Inflammation and Disease
- Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Mitchell T Wallin et al. LANCET NEUROLOGY
- Association of acute stress with multiple sclerosis onset and relapse in Saudi Arabia
- (2019) Anwar AlZahrani et al. SAUDI MEDICAL JOURNAL
- Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes
- (2019) Henrike J. Fischer et al. Frontiers in Immunology
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey
- (2018) Tara A. Nazareth et al. Multiple Sclerosis and Related Disorders
- Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled – MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Manuel Comabella Multiple Sclerosis Journal
- Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled – MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Manuel Comabella Multiple Sclerosis Journal
- Relapse in multiple sclerosis
- (2015) I. Galea et al. BMJ-British Medical Journal
- Relapse in multiple sclerosis
- (2015) I. Galea et al. BMJ-British Medical Journal
- Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
- (2015) Andrew J. Steelman Frontiers in Immunology
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
- (2014) Niklas Bergvall et al. PLoS One
- Viruses and Multiple Sclerosis
- (2012) Jussi Oskari Virtanen et al. CNS & Neurological Disorders-Drug Targets
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now